Prof. Ho-Youn KIM (Korea)

Education
1972 B.S., Pre-professional Studies, Catholic University Medical College, Seoul, Korea
1976
 M.S., Medicine, Catholic University Medical College, Seoul, Korea
1983 Ph.D., Medicine, Catholic University Medical College, Seoul, Korea


Postgraduate Qualifications
Mar 1972 - Feb 1977 Internship and Residency, Internal Medicine
Catholic University Medical College, Seoul, Korea
Mar 1977 - Mar 1980
 Medical Officer (Military Service)
Mar 1983 - Mar 1984 Research fellow in Rheumatology
University of Tennessee, Memphis, Tennessee, USA

Appointments

May 1980 - Feb 1983 Instructor, Dept. of Internal Medicine
Catholic University Medical College, Seoul, Korea
Mar 1983 - Feb 198 visiting fellow,
University of Tennessee,USA
Mar 1984 - Feb 1988 Assistant professor Dept. of Internal Medicine
Catholic University Medical College, Seoul, Korea
Mar 1987 – Feb 1988 committee member, HIV subcommittee of Ministry for Health
Mar 1988 - Feb 1994 Associate professor Dept. of Internal Medicine
Catholic University Medical College, Seoul, Korea
Mar 1994 –present Professor, Dept. of Internal Medicine
Mar 1992- Feb 2006 The 1st Chief, Division of Rheumatology/ Immunology
Catholic University Medical College, Seoul, Korea
Mar 1996 – Feb 2002 Director, Research Institute of Immunobiology
Sep 2001- Aug 200 Chairman of Internal medicine of Kangnam St. Mary's Hospital
Sep 2001 - Aug 2003 passing through the secondary course of healthcare management ofthe school of healthcare management
Jul 2002 - Present Director, Rheumatism Research Center
The Catholic University of Korea, College of Medicine
Apr 2006 – Apr 2008 committee member, the Healthcare Policy Deliberation Committee of the Ministry of Health and Welfare
Mar 2009 – Present Director, Rheumatism Center, Seoul St. Mary's hospital
Dec 2009 - Present Head professor of Internal medicine department, Seoul St. Mary's Hospital


Publications
SCI/SCIE (Research)

  1. Ko HY, Cho ML, Lee SY, Oh HJ, Her YJ, Moon YM, Kang CM, Kwok SK, Ju JH, Park SH, Park KS, Kim HY. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population. J Autoimmunity. 2010;34:111-20.
  2. Park MJ, Min SY, Park KS, Cho YG, Cho ML, Jung YO, Park HS, Chang SH, Cho SG, Min JK, Park SH, Kim HY. Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model. Arthritis Research & Therapy. 2008;10:R11
  3. Ju JH, Cho ML, Moon YM, Oh HJ, Park JS, Jhun JY, Min SY, Cho YG, Park KS, Yoon CH, Min JK, Park SH, Sung YC, Kim HY. IL-23 induces receptor activator of NF-kappaB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model. Journal of Immunology. 2008;181:1507-18
  4. Cho ML, Kang JW, Moon YM, Nam HJ, Jhun JY, Heo SB, Jin HT, Min SY, Ju JH, Park KS, Cho YG, Yoon CH, Park SH, Sung YC, Kim HY. STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. Journal of Immunology. 2006;176:5652-61
  5. Min SY, Park KS, Cho ML, Kang JW, Cho YG, Hwang SY, Park MJ, Yoon CH, Min JK, Lee SH, Park SH, Kim HY. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis. Arthritis and Rheumatism. 2006;54(3):887-98
  6. Min SY, Hwang SY, Park KS, Lee JS, Lee KE, Kim KW, Jung YO, Koh HJ, Do JH, Kim H, Kim HY. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen. Arthritis Res Ther. 2004;6:R213-9
  7. Cho ML, Yoon CH, Hwang SY, Park MK, Min SY, Lee SH, Park SH, Kim HY. Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts. Arthritis and Rheumatism. 2004;50:776-84.
  8. Min DJ, Cho ML, Lee SH, Min SY, Kim WU, Min JK, Park SH, Cho CS, Kim HY. Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts. Arthritis and Rheumatism. 2004;50:1146-55
  9. Kim WU, Lee WK, Ryoo JW, Kim J, Hwang SY, Min JK, Park SH, Cho CS. Kim HY. Suppression of collagen induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping CII: a novel therapeutic strategy for oral tolerance induction. Arthritis and Rheumatism. 2002;46:1109-20
  10. Park SH, Min DJ, Cho ML, Kim WU, Youn J, Park W, Cho CS, Kim HY. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. Arthritis and Rheumatism. 2001;44:561-69
  11. Kim HY, Kim WU, Cho ML, Lee SK, Youn JH, Kim SI, Yoo WH, Park JH, Min JK, Lee SH, Park SH, Cho CS. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis and Rheumatism. 1999;42:2085-93

SCI/SCIE (Review)

  1. Park KS, Park MJ, Kwok SK, Ju JH, Ko HJ, Park SH, Kim HY. Type II collagen oral tolerance ; Mechanism and role in collagen-induced arthritis and rheumatoid arthritis. Mod Rheumatol. 2009;19:581-9.
  2. Ju JH, Min JK, Jung CK, Oh SN, Kwok SK, Kang KY, Park KS, Ko HJ, Yoon CH, Park SH, Cho CS, Kim HY. Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nat Rev Rheumatol. 2009;5:273-81.